These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3503686)

  • 1. Restless legs syndrome and Parkinson's disease: insights into pathophysiology.
    Lang AE
    Clin Neuropharmacol; 1987 Oct; 10(5):476-8. PubMed ID: 3503686
    [No Abstract]   [Full Text] [Related]  

  • 2. Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease.
    Rios Romenets S; Dauvilliers Y; Cochen De Cock V; Carlander B; Bayard S; Galatas C; Wolfson C; Postuma RB
    Parkinsonism Relat Disord; 2013 Jan; 19(1):92-4. PubMed ID: 22922159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord mechanisms in amitriptyline responsive restless legs syndrome in Parkinson's disease.
    Sandyk R; Iacono RP; Bamford CR
    Int J Neurosci; 1988 Jan; 38(1-2):121-4. PubMed ID: 3356496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Istradefylline for Restless Legs Syndrome Associated with Parkinson's Disease.
    Nuermaimaiti M; Oyama G; Kasemsuk C; Hattori N
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():521. PubMed ID: 29423337
    [No Abstract]   [Full Text] [Related]  

  • 5. Restless legs syndrome in Parkinson's disease.
    Tan EK; Lum SY; Wong MC
    J Neurol Sci; 2002 Apr; 196(1-2):33-6. PubMed ID: 11959153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectrum of levodopa-related fluctuations in Parkinson's disease.
    Riley DE; Lang AE
    Neurology; 1993 Aug; 43(8):1459-64. PubMed ID: 8350996
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sleep disorders in Parkinson's disease: REM sleep behaviour disorder and restless legs syndrome].
    Jáuregui-Barrutia A; Tijero-Merino B; Gómez-Esteban JC; Zarranz JJ
    Rev Neurol; 2010 Feb; 50 Suppl 2():S15-9. PubMed ID: 20205137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs symptoms in a patient with above knee amputations: a case of phantom restless legs.
    Hanna PA; Kumar S; Walters AS
    Clin Neuropharmacol; 2004; 27(2):87-9. PubMed ID: 15252270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restlessness restricted to the perianal region in a patient with Parkinson's disease.
    Okamura M; Suzuki K; Matsubara T; Hirata K
    Parkinsonism Relat Disord; 2018 Jun; 51():117-118. PubMed ID: 29506822
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioids, dopamine, and restless legs syndrome.
    Gillman MA; Sandyk R
    Am J Psychiatry; 1985 May; 142(5):662. PubMed ID: 3985214
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.
    Nomura T; Inoue Y; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):39-44. PubMed ID: 16899256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Parkinson's disease and restless legs syndrome/Willis-Ekbom disorder link: evidences, biases and clinical relevance.
    Munhoz RP; Constantino MCL; Silveira-Moriyama L
    Arq Neuropsiquiatr; 2019 Jan; 77(1):47-54. PubMed ID: 30758442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restless legs syndrome in Parkinson's disease: clinical characteristics and biochemical correlations.
    Guerreiro TM; Nishikawa DR; Ferreira LC; Melo HA; Prado RC
    Arq Neuropsiquiatr; 2010 Dec; 68(6):869-72. PubMed ID: 21243243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
    Bayard S; Cochen De Cock V; Dauvillers Y
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restless legs syndrome in Korean patients with drug-naïve Parkinson's disease: a nation-wide study.
    Shin HY; Youn J; Yoon WT; Kim JS; Cho JW
    Parkinsonism Relat Disord; 2013 Mar; 19(3):355-8. PubMed ID: 23047004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease.
    Kedia S; Moro E; Tagliati M; Lang AE; Kumar R
    Neurology; 2004 Dec; 63(12):2410-2. PubMed ID: 15623715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intertemporal choice in Parkinson's disease and restless legs syndrome.
    Al-Khaled M; Heldmann M; Bolstorff I; Hagenah J; Münte TF
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1330-5. PubMed ID: 26427640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A preliminary study on the clinical characteristics of Parkinson's disease patients with restless legs syndrome].
    Zhang H; Luo C; Huang TT; Zhang Y; Lu ZN
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(39):3089-3092. PubMed ID: 29081154
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Parkinson's disease and restless legs syndrome with cabergoline, a long-acting dopamine agonist.
    Porter MC; Appiah-Kubf LS; Chaudhuri KR
    Int J Clin Pract; 2002; 56(6):468-74. PubMed ID: 12166546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restless legs syndrome and periodic leg movements in patients with movement disorders: Specific considerations.
    Högl B; Stefani A
    Mov Disord; 2017 May; 32(5):669-681. PubMed ID: 28186669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.